Totally, axitinib-induced senescence (increased cell size and increased expression of β-gal) in a panel of cancer cells lines was unrelated to the expression of VEGFRs and VEGFR signaling, indicating that axitinib induced senescence independently of its inhibitory effect on VEGFR signaling. This evidence concerns the gene KDR and cancer.